July 5, 2016

We hope you can join us for the NRG Oncology Semiannual Meeting, July 14-16, 2016 at the Sheraton Dallas Hotel in Dallas, TX. Pre-registration is now closed. Please register onsite for this meeting.

Attention NRG Oncology Semiannual Meeting Attendees: Get the free meeting app – EventsXD – on your iOS, Android, or Windows device to quickly access agendas, meeting room information, and more!

Summer Symposium - “Endometrial Cancer: The Future of Targeted Therapy”
Thursday, July 14, 2016, 8:00 am-2:30 pm
Program Description

Scientific Session - NRG Oncology Research Review
Friday, July 15, 2016, 8:00-10:00 am

Dr. Marvella Ford to speak at special NRG Oncology Workshop on Cultural Competency in Clinical Trials
This workshop, on Friday, July 15, at 11 am, is designed for NRG Oncology research investigators, nurses, CRAs, and support staff to understand the role cultural competency plays in clinical trials. With recruitment of patients from underrepresented minority groups in clinical trials at less than 1%, there is an opportunity to reduce this gap in health disparity! Don't forget to register.

CCD 800-line coverage during the meeting
Information regarding the availability of the NRG Oncology-Pittsburgh Center Clinical Coordinating Department (CCD) during the NRG Oncology meeting is posted to the NRG Oncology and CTSU websites.

NRG-GY001: Amendment 2; Version date: May 25, 2016. Documents posted on the CTSU website

NRG-HN002: Amendment 3; Version Date: May 24, 2016, has been approved by Health Canada. Sites in Canada can access the NOL and TPD forms on the CTSU website

NSABP B-38: Final Study Closure Notice and Patient Letter (posted to NSABP and CTSU)

GOG 0237: Changes to Specimen Submission and Testing

:Phase II and Rare Tumor Trial Availability List

Vision Tree Webinar
The next VTOC training session will be face to face at the NRG semiannual meeting July 14, 2016, at 1 pm CDT. The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, and NRG-HN002. Space is limited so register now and reserve your seat. The next webinar training is scheduled for August 10, 2016.

Safety updates have been issued for GOG legacy studies. For details, please see the GOG Weekly Mailing page.

An IB update has been issued for an NSABP legacy study. For details, please see the NSABP Members' Area or the E-mail Distributions page and the CTSU website.

Safety updates have been issued for the following NRG Oncology studies:
Ipilimumab: NRG-GY003
Nivolumab: NRG-GY002, NRG-GY003
For NRG-GY002 and NRG-GY003 safety reports, please see the protocol page on the NRG Oncology website for details.

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

Monk BJ, Sill MW, Walker JL, Darus CJ, Sutton G, Tewari KS, Martin LP, Schilder JM, Coleman RL, Balkissoon J, Aghajanian C. Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study. J Clin Oncol. 2016 July 1; 34(19):2279-86 doi:10.1200/JCO.2015.65.8153. Epub 2016 May 23. PubMed PMID: 27217446. Read more

Please note the following upcoming meeting and abstract submission deadline dates.

Upcoming Meetings
American Head & Neck Society (AHNS), Jul 16-20, 2016; Seattle, WA

American Association of Physicists in Medicine (AAPM)
, Jul 31-Aug 4, 2016; Washington, DC

Upcoming abstract submission deadlines
European Society for Medical Oncology (ESMO), Oct 7-11, 2016; Copenhagen, Denmark; meeting abstract submission deadline Aug 23, 2016 LBA

Society of Clinical Research (SOCRA)
, Sep 30-Oct 2, 2016; Montreal, QC, Canada; meeting abstracts submission deadline Jul 29, 2016

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103

Update Profile/Email Address